AJAlecia James

Alecia James

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alecia James has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of a Childhood Obesity Program Serving a High-Need Population in Brooklyn, New York Using Survival Analysis

    by Alecia James, Aimee Afable, Nagla Bayoumi, Sarita Dhuper

    In this study, we used survival analysis to evaluate whether contact hours intensity was associated with a reduction in time to improvement of various BMI metrics over a 5-year follow-up period at the Live Light Live Right pediatric obesity program in Brooklyn, New York. This was a single-center retrospective longitudinal study of 406 patients during 2010–2016. Participants were categorized based on hours of exposure to Live Light Live Right’s interventions; high contact hours (≥50 h) vs. low contact hours (<50 h). At baseline, 88% of patients in the high contact hour group had severe obesity and the mean age for this group was 10.0 ± 2.66. High contact hours were independently associated with a shorter time to BMI improvement in the sample. There was also a significant association between high contact hours and a longer duration in the improved state. Survival analysis was successful in evaluating the efficacy of the Live Light Live Right Program and demonstrated a positive association between greater intervention intensity and a healthier metabolic profile. Patients’ active engagement in a robust treatment model exemplified by Live Light Live Right is recommended to address the childhood obesity crisis in central Brooklyn.


  • Analysis of the relationship between social determinants of health and survival outcomes in gestational trophoblastic neoplasia in the United States.

    by Chrissy Liu, Alecia James, Jennifer Wolf, Marcia Schmidt, Edith P. Mitchell, Rose Calixte, Camille A. Clare

    E17537 Background: Gestational trophoblastic neoplasia (GTN) is a rare disease with a reported incidence of 1 in 40,000 pregnancies. There have been no studies evaluating the impact of social determinants of health (SDH) on outcomes in GTN. This study seeks to examine the influence of social and biologic prognostic factors related to survival among women with GTN. We hypothesized that older age at diagnosis, lower household income, and marginalized, racial/ethnic groups are associated with worse prognosis. Methods: In this retrospective study, the Surveillance, Epidemiology, and End Results (SEER) database was used to identify women with GTN diagnosed from 2010-2018. Clinical-pathologic characteristics were described including initial stage of disease, presence of brain metastases at diagnosis, treatment with chemotherapy or surgery, and treatment at a Commission on Cancer (CoC) accredited center. Demographic factors were collected, including race/ethnicity, age at diagnosis, marital status, median household income, and rural or urban location. Log-logistic regression models were used to estimate the association between various prognostic factors and the odds of survival. We compared overall survival distributions across race/ethnicity using the log-rank test. Results: Of the 1,149 eligible patients (pts), 36% were non-Hispanic White (NHW), 21% non-Hispanic Black (NHB), 28% Hispanic, and 14% Other (Native American, Alaska Native, Asian, Pacific Islander). Mean age was 33.8 years (range 14-87 years). The majority was in the 21-35 age group (51%). Compared to NHW pts, Hispanic pts had over two times the odds of increased survival (OR 2.11; 95% CI 1.08-3.27; p = 0.032). NHB pts had similar survival compared to NHW pts (OR 1.06; 95% CI 0.50-1.76; p = 0.860). Poor prognostic factors demonstrating decreased odds of survival included age ≥40 years (OR 0.139; 95% CI 0.025-0.478; p < 0.001) and widowed status (OR 0.09; 95% CI 0.018-0.375; p < 0.001). Localized stage (OR 2.94; 95% CI 1.13-5.53; p = 0.03), the absence of brain metastases (OR 4.58; 95% CI 1.96-7.91; p = 0.002), and rural location (OR 5.62; 95% CI 1.25-15.2; p = 0.028) were significantly associated with increased odds of survival. Household income and race/ethnicity were not independent predictors of survival. Conclusions: Compared to NHW pts, Hispanic pts have an increased cause-specific survival for GTN. NHB pts and NHW pts have similar survival. Additionally, rural location was significantly associated with greater odds of survival. Further research is needed to investigate the underlying mechanisms linking race/ethnicity and survival outcomes, considering structural racism, bias, and discrimination. Our findings highlight the importance of recognizing the role of racism and SDH on health disparities and call to attention the need for addressing social inequities in GTN.

  • Evaluating the impact of social distancing on COVID-19 hospitalizations using interrupted time series regression

    by Alecia James, Rikki Malagón-Morris, Shari Gurusinghe, Patricia Roblin, Christina Bloem, Tyler Wise, Michael A. Joseph, Bonnie Arquilla, Pia Daniel

    Introduction: The quasi-experimental approach of interrupted time series analysis has been used to assess public health interventions by statistically comparing preintervention and postintervention rates. In this study, we apply interrupted time series to assess the effectiveness of social distancing on COVID-19 hospitalizations in a patient population in New York City. Materials and Methods: An interrupted time series design was used to evaluate the impact of the New York State on PAUSE executive order (social distancing measure), on admitted COVID-19 patients, and patients on ventilators, at a single center hospital in Brooklyn, NY. Time series data were collected from March 10, 2020 to April 28, 2020 and were modeled using segmented regression analysis, assuming a 2-week delay in the intervention's effect. ARIMA forecasting was also performed to determine the projected COVID-19 hospitalizations and ventilator use in the absence of social distancing. Results: There was a significant change (decrease) in the upward daily trend in the mean number of COVID-19 admissions and patients on ventilators after the assumed effective date of the New York State on PAUSE mandate. For admitted patients, the coefficient of the variable “time after intervention,” or change in slope, was − 9.30 (P = 0.0009), and the corresponding value was − 2.27 (P < 0.0001) for patients on ventilators. Conclusion: The assumed effective period of the implementation of the New York State on PAUSE executive order was shown to be significantly correlated with decreased COVID-19 hospitalizations and ventilator use in the population measured. Similar social distancing measures should be adopted in other cities and locales that are currently seeing a surge in COVID-19 transmissions with an assumption of a 2-week delay in impact. The following core competencies are addressed in this article: Medical knowledge, Systems-based practice.


  • Open Access

    Procalcitonin Levels in COVID-19 Patients Are Strongly Associated with Mortality and ICU Acceptance in an Underserved, Inner City Population

    by Theresa Feng, Alecia James, Kyra Doumlele, Seth White, Wendy Twardzik, Kanza Zahid, Zeeshan Sattar, Osato Ukponmwan, Mohamd Nakeshbandi, Lillian Chow, et al.

    Background and Objectives: This study aimed to identify demographic and clinical factors at the time of critical care consultation associated with mortality or intensive care unit acceptance in a predominantly Afro-Caribbean population during the first wave of the COVID19 pandemic. Materials and Methods: This retrospective, single-center observational cohort study included 271 COVID19 patients who received a critical care consult between March 11 and April 30, 2020 during the first wave of the COVID19 pandemic at State University of New York Downstate Health Sciences University. Results: Of the 271 patients with critical care consults, 33% survived and 67% expired. At the bivariate level, age, blood urea nitrogen, and blood neutrophil percentage were significantly associated with mortality (mean age: survivors, 61.62 ± 1.50 vs. non-survivors, 68.98 ± 0.85, p < 0.001). There was also a significant association between neutrophil% and mortality in the univariate logistic regression model (quartile 4 vs. quartile 1: odd ratio 2.73, 95% confidence interval (1.28–5.82), p trend = 0.044). In the multivariate analyses, increasing levels of procalcitonin and C-reactive protein were significantly associated with mortality, adjusting for age, sex, and race/ethnicity (for procalcitonin quartile 4 vs. quartile 1: odds ratio 5.65, 95% confidence interval (2.14–14.9), p trend < 0.001). In contrast, higher platelet levels correlated with significantly decreased odds of mortality (quartile 4 vs. quartile 1, odds ratio 0.47, 95% CI (0.22–0.998), p trend = 0.010). Of these factors, only elevated procalcitonin levels were associated with intensive care unit acceptance. Conclusions: Procalcitonin showed the greatest magnitude of association with both death and likelihood of intensive care unit acceptance at the bivariate level. Our data suggests that procalcitonin reflects pneumonia severity during COVID-19 infection. Thus, it may help the intensivist identify those COVID19 patients who require intensive care unit level care.